"When I learned I had a tumor on my spinal cord, doctors told me that without surgery I would be paraplegic but that the extremely delicate and risky surgery would involve removing ribs and intestines," said Carol Alfaro, a spinal tumor patient. "I opted for treatment with the CyberKnife System and with just three, pain-free outpatient visits, I had my life back."

By eliminating the need for invasive surgery, the CyberKnife System allows patients to recover more quickly, experience fewer complications and immediately resume regular daily activities after treatment.


About the CyberKnife® Robotic Radiosurgery System

The CyberKnife System represents the next generation of radiosurgery systems, combining continuous image-guidance technology with a compact linear accelerator that has the flexibility to move in three dimensions according to the treatment plan. This combination, which is referred to as intelligent robotics, extends the benefits of radiosurgery to the treatment of tumors anywhere in the body.

The CyberKnife System autonomously tracks, detects and corrects for tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation typically with sub-millimeter accuracy.

About Accuray Incorporated
Accuray Incorporated (NASDAQ: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery. Its CyberKnife System is the world's first and only commercially available intelligent robotic radiosurgery system designed to treat tumors anywhere in the body, typically with sub-millimeter accuracy. To date, it is estimated that the CyberKnife System has treated more than 20,000 patients worldwide. For more information, please visit www.accuray.com.



Back to HCB News

More Industry Headlines